https://intalyse.ai 2026-11-10 weekly 1.0 https://intalyse.ai/case-intake-automation 2026-11-10 monthly 0.9 https://intalyse.ai/icsr-case-processing 2026-11-10 monthly 0.9 https://intalyse.ai/pharmacovigilance-literature-monitoring 2026-11-10 monthly 0.9 https://intalyse.ai/social-media-pharmacovigilance 2026-11-10 monthly 0.8 https://intalyse.ai/product-complaint-management 2026-11-10 monthly 0.8 https://intalyse.ai/signal-management 2026-11-10 monthly 0.9 https://intalyse.ai/resources 2026-11-10 monthly 0.8 https://intalyse.ai/about 2026-11-10 monthly 0.8 https://intalyse.ai/features 2026-11-10 monthly 0.8 https://intalyse.ai/compliance 2026-11-10 monthly 0.8 https://intalyse.ai/security 2026-11-10 monthly 0.8 https://intalyse.ai/privacy-policy 2026-11-10 monthly 0.8 https://intalyse.ai/data-security-policy 2026-11-10 monthly 0.8 https://intalyse.ai/terms-of-use 2026-11-10 monthly 0.8 https://intalyse.ai/contact 2026-11-10 monthly 0.8 https://intalyse.ai/news 2026-11-10 daily 0.9 https://intalyse.ai/insights 2026-11-10 daily 0.92 https://intalyse.ai/insights/regulatory-updates 2026-11-10 daily 0.86 https://intalyse.ai/news/category/signal-intelligence 2026-09-19 daily 0.7 https://intalyse.ai/news/category/biomedical-literature 2026-09-19 daily 0.7 https://intalyse.ai/news/category/social-media-pharma 2026-09-19 daily 0.7 https://intalyse.ai/news/category/pv-technology 2026-09-19 daily 0.7 https://intalyse.ai/news/category/regulatory-intelligence 2026-09-19 daily 0.7 https://intalyse.ai/news/category/intake-operations 2026-09-19 daily 0.7 https://intalyse.ai/news/signal-intelligence/passive-signals-active-silence-the-accounting-gap-in-federal-vaccine-safety-298e9396 2026-11-10 weekly 0.8 https://intalyse.ai/news/signal-intelligence/regional-trends-in-the-opioid-epidemic-using-safety-signals-of-drug-abuse-e21d1e78 2026-11-10 weekly 0.8 https://intalyse.ai/news/biomedical-literature/ai-agents-in-pharmacovigilance-98248cb4 2026-11-10 weekly 0.8 https://intalyse.ai/news/biomedical-literature/mapping-respiratory-safety-signals-in-glp-1-receptor-agonists-032e108b 2026-11-09 weekly 0.8 https://intalyse.ai/news/signal-intelligence/fda-database-study-differentiates-cutaneous-adverse-events-for-liver-cancer-e8833d5c 2026-11-09 weekly 0.8 https://intalyse.ai/news/intake-operations/a-day-in-the-life-of-a-pharmacovigilance-case-processor-565c80fd 2026-11-08 weekly 0.8 https://intalyse.ai/news/biomedical-literature/disproportionality-analysis-of-adverse-events-post-covid-19-vaccination-a238ffcf 2026-11-07 weekly 0.8 https://intalyse.ai/news/intake-operations/global-pharmacovigilance-and-drug-safety-software-market-insights-7c1a19b2 2026-11-07 weekly 0.8 https://intalyse.ai/news/signal-intelligence/clinical-recognition-and-pharmacovigilance-in-community-pharmacies-71e9cba0 2026-11-07 weekly 0.8 https://intalyse.ai/news/signal-intelligence/global-report-on-pharmacovigilance-and-drug-safety-software-8980851c 2026-11-07 weekly 0.8 https://intalyse.ai/news/signal-intelligence/detection-algorithms-and-attentive-points-of-safety-signal-using-spontaneous-reporting-systems-fed5658b 2026-11-03 weekly 0.8 https://intalyse.ai/news/pv-technology/pharmacovigilance-case-agent-blueprint-0e677ff3 2026-11-03 weekly 0.8 https://intalyse.ai/news/signal-intelligence/consumer-reporting-s-impact-on-signal-detection-in-pharmacovigilance-c522cc5e 2026-10-30 weekly 0.8 https://intalyse.ai/news/intake-operations/pharmacovigilance-data-quality-where-pv-errors-begin-66bde6a8 2026-10-29 weekly 0.8 https://intalyse.ai/news/signal-intelligence/kidney-injury-signals-flagged-for-sacubitril-valsartan-in-japanese-adverse-872580b8 2026-10-28 weekly 0.8 https://intalyse.ai/news/signal-intelligence/disproportionality-analysis-of-acute-kidney-injury-reports-associated-with-sacubitril-valsartan-arni-in-the-japanese-adv-2c69e73c 2026-10-29 weekly 0.8 https://intalyse.ai/news/signal-intelligence/ai-s-role-in-transforming-pharmacovigilance-by-2030-40986a90 2026-10-29 weekly 0.8 https://intalyse.ai/news/signal-intelligence/ai-driven-pharmacovigilance-platforms-set-for-20-2-cagr-growth-2a8fa10f 2026-10-30 weekly 0.8 https://intalyse.ai/news/signal-intelligence/ai-driven-drug-safety-platforms-set-for-20-2-cagr-growth-by-2026-b9023d7d 2026-10-29 weekly 0.8 https://intalyse.ai/news/signal-intelligence/pharmacovigilance-outsourcing-market-study-highlights-how-industry-demand-is-evolving-b3b2ccbb 2026-10-30 weekly 0.8 https://intalyse.ai/news/biomedical-literature/pharmacovigilance-market-insights-highlight-segment-expansion-and-market-leadership-61fbf01f 2026-10-27 weekly 0.8 https://intalyse.ai/news/biomedical-literature/optimizing-serious-adverse-event-reporting-systems-0edecbbf 2026-10-27 weekly 0.8 https://intalyse.ai/news/signal-intelligence/signal-mining-of-adverse-events-of-antiangiogenic-drugs-in-colorectal-cancer-89da1947 2026-10-29 weekly 0.8 https://intalyse.ai/news/biomedical-literature/reading-safety-data-adverse-events-treatment-discontinuations-and-benefit-risk-balance-8ce28969 2026-10-30 weekly 0.8 https://intalyse.ai/news/pv-technology/gsk-and-cognizant-enhance-drug-safety-with-ai-bc5d95b7 2026-10-26 weekly 0.8 https://intalyse.ai/news/biomedical-literature/when-cancer-immunotherapy-turns-on-the-heart-70165b05 2026-10-24 weekly 0.8 https://intalyse.ai/news/pv-technology/north-america-pharma-cloud-services-market-forecast-to-2035-268df848 2026-10-24 weekly 0.8 https://intalyse.ai/news/intake-operations/how-automation-and-ai-transform-pharmacovigilance-409b588a 2026-10-23 weekly 0.8 https://intalyse.ai/news/pv-technology/which-pharmacovigilance-software-fits-fda-e2b-r3-reporting-in-2026-3e18f88d 2026-10-23 weekly 0.8 https://intalyse.ai/news/biomedical-literature/pharmacovigilance-market-growth-driven-by-drug-safety-needs-86babca6 2026-10-23 weekly 0.8 https://intalyse.ai/news/signal-intelligence/faers-analysis-reveals-signals-for-givinostat-related-to-platelets-and-triglycerides-8c2b7987 2026-10-22 weekly 0.8 https://intalyse.ai/news/pv-technology/ai-s-impact-on-pharmaceutical-quality-systems-under-regulatory-scrutiny-e200f838 2026-10-22 weekly 0.8 https://intalyse.ai/news/signal-intelligence/finerenone-safety-signals-identified-in-us-and-japanese-reports-6290a8ef 2026-10-21 weekly 0.8 https://intalyse.ai/news/signal-intelligence/enhanced-drug-safety-monitoring-essential-for-patient-protection-fddaa48c 2026-10-22 weekly 0.8 https://intalyse.ai/news/signal-intelligence/infectious-complications-and-toxicities-of-teclistamab-plus-daratumumab-55e193b5 2026-10-20 weekly 0.8 https://intalyse.ai/news/signal-intelligence/the-importance-of-translating-pharmacovigilance-reports-31911972 2026-10-20 weekly 0.8 https://intalyse.ai/news/intake-operations/ai-and-automation-transforming-pharmacovigilance-operations-15d18ef9 2026-10-20 weekly 0.8 https://intalyse.ai/news/biomedical-literature/explore-21-essential-pharma-and-biotech-software-tools-a1228c01 2026-10-21 weekly 0.8 https://intalyse.ai/news/signal-intelligence/psychiatric-adverse-events-linked-to-lebrikizumab-a-faers-analysis-16940da6 2026-10-21 weekly 0.8 https://intalyse.ai/news/biomedical-literature/pharmacovigilance-in-clinical-trials-current-practice-and-challenges-1e73b78a 2026-10-18 weekly 0.8 https://intalyse.ai/news/pv-technology/artificial-intelligence-is-transforming-pharmacovigilance-9f1e8081 2026-10-19 weekly 0.8 https://intalyse.ai/news/biomedical-literature/medical-literature-monitoring-services-by-pharma-wizard-consultancy-e14fa41e 2026-10-19 weekly 0.8 https://intalyse.ai/news/biomedical-literature/hospital-ehr-alert-system-reduces-risky-drug-herb-interactions-37ac6eea 2026-10-17 weekly 0.8 https://intalyse.ai/news/signal-intelligence/lecanemab-shows-safety-profile-with-stroke-signal-in-real-world-data-343790f1 2026-10-17 weekly 0.8 https://intalyse.ai/news/pv-technology/sr-pharmacovigilance-pv-clinical-scientist-contract-role-afe06e64 2026-10-21 weekly 0.8 https://intalyse.ai/news/signal-intelligence/adverse-event-reporting-patterns-of-tobacco-cessation-medications-in-korea-4489a1b8 2026-10-17 weekly 0.8 https://intalyse.ai/news/biomedical-literature/real-world-data-could-finally-crack-the-evidence-gap-for-the-tiniest-babies-9c910f13 2026-10-15 weekly 0.8 https://intalyse.ai/news/biomedical-literature/welo-life-sciences-unveils-ai-driven-glass-pv-for-pharmacovigilance-07857938 2026-10-16 weekly 0.8 https://intalyse.ai/news/signal-intelligence/enhancing-gxp-audit-effectiveness-fdc4f12e 2026-10-16 weekly 0.8 https://intalyse.ai/news/biomedical-literature/evaluating-adverse-events-in-clinical-trials-2ad97b43 2026-10-15 weekly 0.8 https://intalyse.ai/news/intake-operations/enhancing-pharmacovigilance-with-ai-driven-case-intake-join-our-webinar-423de21f 2026-10-17 weekly 0.8 https://intalyse.ai/news/pv-technology/global-pharmacovigilance-market-forecast-ai-and-cloud-innovations-9bd6eb11 2026-10-12 weekly 0.8 https://intalyse.ai/news/signal-intelligence/disproportionality-analysis-of-faers-data-divergence-and-a-systematic-review-of-comparative-safety-studies-lessons-learn-ff3f1274 2026-10-16 weekly 0.8 https://intalyse.ai/news/pv-technology/ai-driven-pharmacovigilance-enhancing-safety-operations-3522c8c0 2026-10-10 weekly 0.8 https://intalyse.ai/news/signal-intelligence/pharmtech-ai-pulse-check-on-prem-vs-cloud-ai-872ad38d 2026-10-10 weekly 0.8 https://intalyse.ai/news/pv-technology/thunk-ai-unveils-open-benchmark-for-ai-in-pharmacovigilance-a529309f 2026-10-09 weekly 0.8 https://intalyse.ai/news/signal-intelligence/pharmacovigilance-system-senior-specialist-position-at-cencora-0ea03253 2026-10-09 weekly 0.8 https://intalyse.ai/news/pv-technology/rethinking-artificial-intelligence-within-pharma-supply-chains-3163d45f 2026-10-08 weekly 0.8 https://intalyse.ai/news/pv-technology/pharmacovigilance-outsourcing-market-set-to-reach-usd-16-3-billion-by-2036-8ba521f3 2026-10-07 weekly 0.8 https://intalyse.ai/news/signal-intelligence/ai-software-compliance-audits-in-pharma-complete-2026-guide-c7f41de5 2026-10-09 weekly 0.8 https://intalyse.ai/news/pv-technology/postvaccine-hepatitis-reports-more-often-serious-in-children-vs-adults-851582c7 2026-10-07 weekly 0.8 https://intalyse.ai/news/pv-technology/the-growing-importance-of-social-listening-in-medical-affairs-61a297b8 2026-10-07 weekly 0.8 https://intalyse.ai/news/biomedical-literature/streamlining-adverse-event-reporting-in-trials-43bfb764 2026-10-07 weekly 0.8 https://intalyse.ai/news/signal-intelligence/ai-revolutionizes-pharmacovigilance-practices-6b5d6311 2026-10-11 weekly 0.8 https://intalyse.ai/news/signal-intelligence/pharmacovigilance-software-is-having-its-salesforce-moment-8c6e4128 2026-10-06 weekly 0.8 https://intalyse.ai/news/biomedical-literature/bone-and-growth-safety-profiles-of-dmards-in-juvenile-idiopathic-arthritis-de3ccfe0 2026-10-07 weekly 0.8 https://intalyse.ai/news/intake-operations/understanding-seriousness-assessment-in-icsrs-c7a3849c 2026-10-07 weekly 0.8 https://intalyse.ai/news/pv-technology/post-marketing-reporting-patterns-of-ceftazidime-avibactam-and-ceftolozane-tazobactam-f4383fb5 2026-10-05 weekly 0.8 https://intalyse.ai/news/signal-intelligence/hair-loss-signals-emerge-in-fda-database-as-biologics-draw-new-safety-a7ec6a92 2026-10-04 weekly 0.8 https://intalyse.ai/news/pv-technology/redefining-pharmacovigilance-through-digital-innovation-244b4f32 2026-10-04 weekly 0.8 https://intalyse.ai/news/biomedical-literature/elsevier-withdraws-study-linking-vaccines-to-sids-a75cc6d3 2026-10-04 weekly 0.8 https://intalyse.ai/news/intake-operations/top-ai-translation-services-for-pharmacovigilance-687102b4 2026-10-03 weekly 0.8 https://intalyse.ai/news/biomedical-literature/pharmtech-ai-pulse-check-episode-2-shadow-ai-trade-secrets-the-api-race-1fe67cd4 2026-10-03 weekly 0.8 https://intalyse.ai/news/biomedical-literature/trevogrumab-maintains-lean-mass-in-semaglutide-weight-loss-study-d86d8a00 2026-10-02 weekly 0.8 https://intalyse.ai/news/social-media-pharma/navigating-social-media-regulations-in-pharma-1cc0ff09 2026-10-02 weekly 0.8 https://intalyse.ai/news/pv-technology/global-databases-reveal-hidden-risks-of-riociguat-57508743 2026-10-02 weekly 0.8 https://intalyse.ai/news/social-media-pharma/advancing-pharma-s-social-media-listening-analytics-92f9671d 2026-10-02 weekly 0.8 https://intalyse.ai/news/signal-intelligence/global-pharmacovigilance-market-2026-2031-growth-driven-by-expanding-drug-development-pipelines-and-ai-enabled-signal-de-19d26d36 2026-10-01 weekly 0.8 https://intalyse.ai/news/pv-technology/key-tech-systems-within-the-pharmaceuticals-value-chain-1506a552 2026-10-07 weekly 0.8 https://intalyse.ai/news/pv-technology/ai-revolutionizing-safety-operations-c3cfa62d 2026-10-02 weekly 0.8 https://intalyse.ai/news/pv-technology/zeleciment-basivarsen-demonstrates-lasting-benefits-in-myotonic-dystrophy-type-1-03a28ccc 2026-09-30 weekly 0.8 https://intalyse.ai/news/signal-intelligence/global-to-local-pharmacovigilance-governance-guide-for-mahs-9dc03ae6 2026-09-30 weekly 0.8 https://intalyse.ai/news/signal-intelligence/global-clinical-safety-pharmacovigilance-services-market-forecast-2026-2032-e765b5a5 2026-09-29 weekly 0.8 https://intalyse.ai/news/signal-intelligence/harmonization-in-pharmacovigilance-in-2026-pv-rules-f7769f48 2026-09-29 weekly 0.8 https://intalyse.ai/news/social-media-pharma/social-media-allows-patients-to-discuss-less-frequent-glp-1-adverse-effects-952e0000 2026-09-28 weekly 0.8 https://intalyse.ai/news/biomedical-literature/automated-pharmacovigilance-literature-monitoring-441dde4b 2026-09-27 weekly 0.8 https://intalyse.ai/news/social-media-pharma/pharmacovigilance-and-social-media-monitoring-drug-safety-in-the-digital-age-85480dee 2026-09-26 weekly 0.8 https://intalyse.ai/news/biomedical-literature/the-role-of-artificial-intelligence-in-reducing-adverse-events-in-modern-pharmacology-4aed7619 2026-09-26 weekly 0.8 https://intalyse.ai/news/signal-intelligence/understanding-case-assessments-in-pharmacovigilance-4b4837d2 2026-09-26 weekly 0.8 https://intalyse.ai/news/signal-intelligence/aggregate-reporting-in-pv-in-2026-psur-pbrer-dsur-1a8c3f20 2026-09-26 weekly 0.8 https://intalyse.ai/news/pv-technology/exciting-opportunity-safety-medical-writer-at-merck-bangalore-3471ccc3 2026-09-24 weekly 0.8 https://intalyse.ai/news/pv-technology/pharmacovigilance-software-market-growth-forecast-9da6a2f4 2026-09-24 weekly 0.8 https://intalyse.ai/news/pv-technology/pharmacovigilance-outsourcing-market-set-for-significant-growth-02332eba 2026-09-23 weekly 0.8 https://intalyse.ai/news/biomedical-literature/exploring-clinical-research-paths-post-b-pharmacy-5c666ea2 2026-09-23 weekly 0.8 https://intalyse.ai/news/pv-technology/pharmacovigilance-vendor-management-beyond-qualification-f398c60f 2026-09-23 weekly 0.8 https://intalyse.ai/news/signal-intelligence/comparative-analysis-of-adr-reporting-in-clinical-settings-84ced06c 2026-09-23 weekly 0.8 https://intalyse.ai/news/biomedical-literature/pubhive-recognized-as-leading-ai-driven-pharmacovigilance-platform-39541a19 2026-09-25 weekly 0.8 https://intalyse.ai/news/signal-intelligence/types-of-pharmacovigilance-in-2026-pv-methods-guide-3f57697b 2026-09-24 weekly 0.8 https://intalyse.ai/news/pv-technology/can-ai-help-pharma-identify-patient-safety-risks-earlier-248c4d0a 2026-09-24 weekly 0.8 https://intalyse.ai/news/signal-intelligence/pharmacovigilance-practices-in-university-and-teaching-hospitals-fafc73ca 2026-09-24 weekly 0.8 https://intalyse.ai/news/signal-intelligence/signal-detection-of-adverse-events-associated-with-pcsk9-inhibitors-f4972565 2026-09-23 weekly 0.8 https://intalyse.ai/news/biomedical-literature/clinical-evidence-of-orally-administered-herbal-preparations-for-supportive-cancer-care-88416ff2 2026-09-22 weekly 0.8 https://intalyse.ai/news/pv-technology/health-ministry-launches-biovigilance-programme-for-drug-monitoring-5ae94b98 2026-09-22 weekly 0.8 https://intalyse.ai/news/biomedical-literature/the-bmj-s-role-in-antivax-narratives-a-critical-examination-1983095c 2026-09-21 weekly 0.8 https://intalyse.ai/news/signal-intelligence/pharmacovigilance-market-to-reach-us-15-7-billion-by-2033-b76ae1f3 2026-09-21 weekly 0.8 https://intalyse.ai/news/signal-intelligence/pharmacovigilance-software-market-set-to-surge-with-ai-innovations-ea07432d 2026-09-21 weekly 0.8 https://intalyse.ai/news/signal-intelligence/the-who-isop-pharmacovigilance-curriculum-2026-update-e96b7ee0 2026-09-20 weekly 0.8 https://intalyse.ai/news/social-media-pharma/will-ai-replace-pharmacovigilance-jobs-reddit-workflow-pain-points-automation-risk-drug-safety-skills-that-gain-value-261ba0a0 2026-09-20 weekly 0.8 https://intalyse.ai/news/signal-intelligence/pharmacovigilance-explained-how-pharma-monitors-drug-safety-and-manages-adverse-events-3100656c 2026-09-19 weekly 0.8 https://intalyse.ai/news/signal-intelligence/fda-aware-of-covid-vaccine-safety-algorithm-limitations-2da2f7a1 2026-09-20 weekly 0.8 https://intalyse.ai/news/biomedical-literature/the-pitfalls-of-disproportionality-analysis-insights-on-their-interwoven-complexity-and-a-front-end-mitigation-strategy-6f2db566 2026-09-20 weekly 0.8 https://intalyse.ai/news/biomedical-literature/interpreting-positive-and-inverse-disproportionality-signals-in-spontaneous-reporting-systems-a-claim-strength-framework-560d7798 2026-09-20 weekly 0.8 https://intalyse.ai/news/intake-operations/where-connected-pharmacovigilance-is-headed-next-a32fde46 2026-09-20 weekly 0.8 https://intalyse.ai/news/social-media-pharma/is-pharmacovigilance-a-good-career-in-2026-reddit-experiences-on-hiring-pay-remote-work-long-term-growth-c372f421 2026-09-19 weekly 0.8 https://intalyse.ai/news/pv-technology/understanding-pharmacovigilance-and-drug-safety-3960074d 2026-09-20 weekly 0.8 https://intalyse.ai/news/pv-technology/building-a-value-driven-platform-in-biopharma-c71f7b03 2026-09-20 weekly 0.8 https://intalyse.ai/news/signal-intelligence/pharmacovigilance-market-outlook-2026-2030-dfcb1574 2026-09-20 weekly 0.8